Protalix BioTherapeutics
PLX
#8575
Rank
โ‚น10.32 B
Marketcap
โ‚น140.23
Share price
-1.78%
Change (1 day)
19.33%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -โ‚น1.1 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are โ‚น38.05 Million. In 2023 the company made an earning of โ‚น0.99 Billion, an increase over its 2022 earnings that were of -โ‚น1.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น1.1 Billion-210.4%
2023 โ‚น0.99 B-199.05%
2022 -โ‚น1.01 Billion-40.38%
2021 -โ‚น1.69 Billion-732.31%
2020 โ‚น0.26 B-130.53%
2019 -โ‚น0.88 Billion189.85%
2018 -โ‚น0.31 Billion-95.29%
2017 -โ‚น6.39 Billion308.12%
2016 -โ‚น1.57 Billion-32.37%
2015 -โ‚น2.32 Billion10.11%
2014 -โ‚น2.1 Billion-7.59%
2013 -โ‚น2.28 Billion
2011 -โ‚น2.64 Billion-19.39%
2010 -โ‚น3.27 Billion20.87%
2009 -โ‚น2.71 Billion32.26%
2008 -โ‚น2.05 Billion-5.46%
2007 -โ‚น2.16 Billion
2004 -โ‚น13.99 Million12.35%
2003 -โ‚น12.46 Million-11.1%
2002 -โ‚น14.01 Million-57.03%
2001 -โ‚น32.59 Million1.03%
2000 -โ‚น32.26 Million-53.22%
1999 -โ‚น68.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น8.44 Billion 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น55.47 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น102.39 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น69.86 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel